Medtronic plc
MDT · NYSE
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2023 FY | 31.23B | 20.51B | 5.49B | 3.76B | 2.83 |
| 2024 FY | 32.36B | 21.15B | 5.14B | 3.68B | 2.77 |
| 2025 FY | 33.54B | 21.91B | 5.96B | 4.66B | 3.63 |
| 2026 FY | 36.36B | 23.64B | 6.47B | 4.80B | 3.75 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2023 FY | 90.95B | 39.28B | 1.54B | 24.36B | 51.48B |
| 2024 FY | 89.98B | 39.56B | 1.28B | 25.02B | 50.21B |
| 2025 FY | 91.68B | 43.42B | 2.22B | 28.52B | 48.02B |
| 2026 FY | 93.03B | 42.96B | 1.95B | 27.96B | 49.46B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2023 FY | 6.04B | -1.46B | 4.58B | -3.62B | -2.17B |
| 2024 FY | 6.79B | -1.59B | 5.20B | -3.67B | -259.00M |
| 2025 FY | 7.04B | -1.86B | 5.19B | -3.59B | 934.00M |
| 2026 FY | 7.33B | -1.90B | 5.43B | -3.64B | -269.00M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2026 FY | 106.80B | 132.81B | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2026 Q1 | 8.58B | 4.95B | 1.45B | 1.04B | 0.81 |
| 2026 Q2 | 8.96B | 5.41B | 1.69B | 1.37B | 1.07 |
| 2026 Q3 | 9.02B | 5.85B | 1.77B | 1.14B | 0.89 |
| 2026 Q4 | 9.81B | 7.44B | 1.56B | 1.24B | 0.98 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2026 Q1 | 90.97B | 42.84B | 1.27B | 28.61B | 47.89B |
| 2026 Q2 | 91.35B | 42.49B | 1.28B | 29.10B | 48.65B |
| 2026 Q3 | 91.49B | 42.29B | 1.15B | 28.07B | 48.99B |
| 2026 Q4 | 93.03B | 42.96B | 1.95B | 27.96B | 49.46B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2026 Q1 | 1.09B | -504.00M | 584.00M | -910.00M | -945.00M |
| 2026 Q2 | 925.00M | -468.00M | 457.00M | -910.00M | 9.00M |
| 2026 Q3 | 2.74B | -444.00M | 2.30B | -911.00M | -135.00M |
| 2026 Q4 | 2.57B | -488.00M | 2.09B | -908.00M | 802.00M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2026 Q1 | 119.11B | 146.45B | — | — | — |
| 2026 Q2 | 120.07B | 147.88B | — | — | — |
| 2026 Q3 | 129.34B | 156.26B | — | — | — |
| 2026 Q4 | 106.80B | 132.81B | — | — | — |